Spinogenix Recognizes Dr. Craig Erickson following $17.25 Million Autism Research Grant to Cincinnati Children's Hospital

Grant Will Support Spinogenix Chief Medical Advisor's Research into Precision Medicine and EEG LOS ANGELES, June 15, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve the...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.